Related Experiment Video

Updated: Aug 7, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

A new combination vaccine for measles, mumps, rubella and varicella

Grazyna Zareba1

  • 1Department of Environmental Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, New York 14642, USA. grazyna_zareba@urmc.rochester.edu

Drugs of Today (Barcelona, Spain : 1998)
|June 28, 2006
PubMed

Insights

ProQuad is a new combination vaccine offering protection against measles, mumps, rubella, and varicella in children. Clinical studies show it is safe and effective, simplifying childhood immunizations.

Area of Science:

  • Pediatric Vaccinology
  • Immunology
  • Public Health

Background:

  • ProQuad is a recently approved combination vaccine for simultaneous vaccination against measles, mumps, rubella, and varicella in children aged 12 months to 12 years.
  • It combines Measles, Mumps, Rubella Virus Vaccine Live (M-M-R II) and Varicella Virus Vaccine Live (Varivax).
  • While measles, mumps, and rubella vaccination coverage is high, varicella vaccination uptake is lower at approximately 84%.

Purpose of the Study:

  • To evaluate the immunogenicity and efficacy of the ProQuad combination vaccine.
  • To assess the safety and tolerability profile of ProQuad compared to its individual components.
  • To highlight the potential benefits of ProQuad in simplifying immunization delivery and improving vaccination coverage.

Main Methods:

  • Clinical studies were conducted to assess ProQuad's immunogenicity and efficacy.
  • Seroconversion rates and antibody response magnitude were measured.
  • Incidence of local and systemic adverse effects was recorded and compared to component vaccines.

Main Results:

  • ProQuad demonstrated seroconversion rates and antibody response magnitude similar to individual M-M-R II and Varivax vaccines.
  • The incidence of local and systemic adverse effects was similar to or lower than that observed with component vaccines.
  • ProQuad was found to be highly immunogenic with a good safety profile.

Conclusions:

  • ProQuad is a safe and effective combination vaccine for measles, mumps, rubella, and varicella.
  • Its use simplifies immunization delivery, potentially improving timely vaccination coverage and reducing healthcare costs.
  • ProQuad facilitates the integration of varicella vaccination into routine childhood immunization schedules, protecting children from four serious diseases.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.